Literature DB >> 17083568

Increased susceptibility to hepatocarcinogenicity of Nrf2-deficient mice exposed to 2-amino-3-methylimidazo[4,5-f]quinoline.

Yasuki Kitamura1, Takashi Umemura, Keita Kanki, Yukio Kodama, Sachiko Kitamoto, Koichi Saito, Ken Itoh, Masayuki Yamamoto, Toshiaki Masegi, Akiyoshi Nishikawa, Masao Hirose.   

Abstract

To elucidate the roles of the transcription factor NF-E2-related factor (Nrf2) in hepatocarcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), a mutagenic and carcinogenic heterocyclic amine, Nrf2-deficient mice were treated with 300 p.p.m. IQ in their diet for 1, 4 or 52 weeks. In the long-term experiment, the multiplicity and incidence of liver tumors in male and female IQ-treated Nrf2 deficient (-/-) mice were significantly higher than those in their counterpart wild-type (+/+) mice exposed to IQ. In the short-term experiment, although IQ exposure to Nrf2(+/+) mice of both sexes did not modify UDP-glucuronosyltransferase values, glutathione S-transferase values were significantly increased due to IQ treatment, in contrast to no alteration in male and female Nrf2(-/-) mice. Levels of oxidative stress markers such as 8-hydroxydeoxyguanosine and thiobarbituric acid reactive substances in the livers of all treated mice were not changed by IQ treatment. IQ-specific DNA adduct levels were elevated only in female Nrf2(-/-) mice, although the increase was not significant. IQ treatment caused an increase in proliferating cell nuclear antigen labeling indices only in male Nrf2(-/-) mice. The present data clearly show that Nrf2(-/-) mice of both sexes are susceptible to IQ hepatocarcinogenicity, which might result from IQ accumulation due to failure of metabolizing enzyme induction. In addition, inconsistent results concerning IQ-specific adducts and proliferating cell nuclear antigen labeling indices in male and female Nrf2(-/-) mice suggest the existence of different contributions of Nrf2 to IQ hepatocarcinogenesis between mice of the two sexes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17083568     DOI: 10.1111/j.1349-7006.2006.00352.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  19 in total

Review 1.  Cancer cell signaling pathways targeted by spice-derived nutraceuticals.

Authors:  Bokyung Sung; Sahdeo Prasad; Vivek R Yadav; Bharat B Aggarwal
Journal:  Nutr Cancer       Date:  2011-12-09       Impact factor: 2.900

Review 2.  p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.

Authors:  Koji Taniguchi; Shinichiro Yamachika; Feng He; Michael Karin
Journal:  FEBS Lett       Date:  2016-08-06       Impact factor: 4.124

Review 3.  Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory.

Authors:  Rong Hu; Constance Lay-Lay Saw; Rong Yu; Ah-Ng Tony Kong
Journal:  Antioxid Redox Signal       Date:  2010-08-17       Impact factor: 8.401

Review 4.  NRF2, cancer and calorie restriction.

Authors:  A Martín-Montalvo; J M Villalba; P Navas; R de Cabo
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

5.  Effect of 7, 8-dihydroxyflavone on the up-regulation of Nrf2-mediated heme oxygenase-1 expression in hamster lung fibroblasts.

Authors:  Min Ju Ryu; Kyoung Ah Kang; Mei Jing Piao; Ki Cheon Kim; Jian Zheng; Cheng Wen Yao; Ji Won Cha; Chang Lim Hyun; Ha Sook Chung; Jong Cook Park; Suk Ju Cho; Jin Won Hyun
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-03-08       Impact factor: 2.416

Review 6.  NRF2 as a regulator of cell metabolism and inflammation in cancer.

Authors:  Feng He; Laura Antonucci; Michael Karin
Journal:  Carcinogenesis       Date:  2020-06-17       Impact factor: 4.944

7.  Genetic or pharmacologic activation of Nrf2 signaling fails to protect against aflatoxin genotoxicity in hypersensitive GSTA3 knockout mice.

Authors:  Kevin H Kensler; Stephen L Slocum; Dionysios V Chartoumpekis; Patrick M Dolan; Natalie M Johnson; Zoran Ilic; Dana R Crawford; Stewart Sell; John D Groopman; Thomas W Kensler; Patricia A Egner
Journal:  Toxicol Sci       Date:  2014-03-27       Impact factor: 4.849

Review 8.  Targeting NRF2 signaling for cancer chemoprevention.

Authors:  Mi-Kyoung Kwak; Thomas W Kensler
Journal:  Toxicol Appl Pharmacol       Date:  2009-09-02       Impact factor: 4.219

Review 9.  Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults.

Authors:  William O Osburn; Thomas W Kensler
Journal:  Mutat Res       Date:  2007-11-23       Impact factor: 2.433

Review 10.  Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression.

Authors:  Jong Hun Lee; Tin Oo Khor; Limin Shu; Zheng-Yuan Su; Francisco Fuentes; Ah-Ng Tony Kong
Journal:  Pharmacol Ther       Date:  2012-10-03       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.